() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

An Introduction to Entheon Biomedical with CEO Timothy Ko

As Psychedelic Medicine seems to be taking the stage for the future, we had the pleasure of learning from the very knowledgeable Timothy Ko the different facets that this entails.
He shares a very intimate story with us about how close to home this topic hits for him and why he has such a deep connection to make this successful in helping those who struggle with addiction.
As Entheon is in the beginning stages, we are happy to be a part of the learning process and suggest you also take it all in and start the deep dive into this sector.

For those who may want a more direct description of the interview, we have time-stamped specific topics discussed for your viewing ease.

(1:15)- Timothy's reasons for entering the space, a very personal story
(3:55)- Substance abuse disorder
(4:50)- Psychedelics role in taking an internal look at trauma
(7:-05)- More to this than jumping on a new stock, Opiates role and purpose
(8:28)- Trauma isn't easily reflected upon- psychedelics can aid in that process
(9:13)- Entheon's purpose & future= classic drug discovery company
(9:45)- DMT and their intent/ R&D
(11:09)- Management team
(13:07)- Protocol design
(14:40)- Investment opportunities

Follow FTMIG on Twitter:
https://mobile.twitter.com/FTMInvest

LIKE FTMIG on Facebook:
https://www.facebook.com/FTMInvest/

Like FTMIG MINING on Facebook:
https://www.facebook.com/FTMIGMining/

Follow FTMIG on Instagram:
https://www.instagram.com/ftminvest/